Influenza vaccine immunogenicity in patients with primary central nervous system malignancy

BACKGROUND: Patients with central nervous system (CNS) malignancies represent an “at-risk” population for contracting influenza, particularly if they are receiving ongoing chemotherapy, radiation, and/or glucocorticoid treatment. The Centers for Disease Control endorses vaccination for these patient...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Strowd, Roy E., Swett, Katrina, Harmon, Michele, Carter, Annette F., Pop-Vicas, Aurora, Chan, Michael, Tatter, Stephen B., Ellis, Thomas, Blevins, Maria, High, Kevin, Lesser, Glenn J.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2014
Sujets:
Clinical Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4232079/
https://ncbi.nlm.nih.gov/pubmed/24714522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou051
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires